In summary, the prevalence of antibodies against nodal/paranodal proteins, such as NF155, CNTN1, and CASPR1, in CIDP is very low, except for the relatively high percentages of Japanese and Chinese CIDP patients who have anti-NF155 antibodies (5, 27). This evidence concerns the gene CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy.